Altimmune, Inc. (ALT) Tops Q1 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.34), $0.04 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• MSCI acquires First Street for $120M to expand climate risk data
• Hyperscale Data signs $1.2B AI compute deal for Michigan campus